|
KR20200082641A
|
|
Pharmaceutical composition comprising dabigatran etexilate
|
|
KR20190084840A
|
|
temperature sensitive polymer composition
|
|
KR20180076903A
|
|
A method for purification of cross-linked hyaluronic acid gel
|
|
KR101802183B1
|
|
Pharmaceutical compositions comprising palonosetron as active ingredient
|
|
SG11201800872QA
|
|
Chimeric antigen receptor, and t cells in which chimeric antigen receptor is expressed
|
|
KR20170101721A
|
|
Formulation containing esomeprazole
|
|
KR101625344B1
|
|
Pharmaceutical compositions comprising celecoxib and duloxetine
|
|
KR20170022790A
|
|
Novel catechol derivatives and pharmaceutical composition comprising the same
|
|
KR20160016725A
|
|
CHIMERIC ANTIGEN RECEPTOR-MODIFIED T CELLS TARGETING IL13Rα2 ON TUMORS
|
|
KR20170008923A
|
|
Pharmaceutical compositions comprising celecoxib and tramadol
|
|
WO2012008697A2
|
|
Orally administered agent for increasing sperm count
|
|
KR20100049897A
|
|
Composition comprising the extract of halocynthia roretzi which contains antimicrobial peptide for preventing and treating gastrointestinal diseases
|
|
KR20100044486A
|
|
Novel crystalline form of amlodipine nicotinate and its preparation method
|
|
KR20100044524A
|
|
Composition comprising the incubated fraction of bacillus polyfermenticus for preventing and treating gastrointestinal diseases
|
|
KR20100044433A
|
|
Composition comprising extract or fraction of chrysanthemum zawadskii for preventing and treating gastrointestinal diseases
|
|
KR100903766B1
|
|
Feed additives for cultivated fish including fermented soybean by bacillus polyfermenticus kjs-2
|
|
KR100856884B1
|
|
Anti-helicobacter pylori macrolactin a that bacillus polyfermenticus kjs-2 produced in
|
